Glycogen Storage Disease Due To Glycogen Debranching Enzyme Deficiency

Description

Glycogen debranching enzyme (GDE) deficiency, or glycogen storage disease type 3 (GSD 3), is a form of glycogen storage disease characterized by severe muscle weakness and hepatopathy.

Clinical Features

Top most frequent phenotypes and symptoms related to Glycogen Storage Disease Due To Glycogen Debranching Enzyme Deficiency

  • Short stature
  • Growth delay
  • Muscle weakness
  • Muscular hypotonia
  • Depressed nasal bridge
  • Motor delay
  • Hepatomegaly
  • Cardiomyopathy
  • Myopathy
  • Intellectual disability, mild

And another 26 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Glycogen Storage Disease Due To Glycogen Debranching Enzyme Deficiency Is also known as gde deficiency, gsd due to glycogen debranching enzyme deficiency, cori-forbes disease, glycogenosis type iii, glycogen storage disease type 3, gsd type 3, limit dextrinosis, glycogen storage disease type iii, glycogenosis type 3, glycogenosis due to glycogen debr.

Researches and researchers

Doctors, researchs, and experts related to Glycogen Storage Disease Due To Glycogen Debranching Enzyme Deficiency extracted from public data.

Glycogen Storage Disease Due To Glycogen Debranching Enzyme Deficiency Experts map



Current Researchs and researchers

  • EVRY — Dr Giuseppe RONZITTI

    Investigator of research project

    • Institution/s:
      — Institut des Biothérapies, Généthon
    • Research area/topic::

      TRACeGSDIII : Translational optimization of AAV vectors to cure GSDIII


  • MILANO — Pr Giacomo Pietro COMI

    Coordinator of expert centre - Principal investigator of clinical trial - Investigator of clinical trial - Investigator of research project - Manager of registry

    • Institution/s:
      — Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
      — Dipartimento di Neuroscienze e Salute Mentale, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
    • Research area/topic::

      Gene therapy and long term evaluation of different dietary regimens in a Glycogen Storage Disease Type III KO mouse model


Glycogen Storage Disease Due To Glycogen Debranching Enzyme Deficiency Recommended genes panels

Panel Name, Specifity and genes Tested/covered
AGL Comprehensive - Sequence & Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories (United States).

AGL
Specificity
100 %
Genes
100 %
AGL Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories (United States).

AGL
Specificity
100 %
Genes
100 %
AGL Sequence Analysis (Prenatal Diagnosis).

By Baylor Miraca Genetics Laboratories (United States).

AGL
Specificity
100 %
Genes
100 %
MitoMet®Plus aCGH Analysis.

By Baylor Miraca Genetics Laboratories (United States).

RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)

View the complete list with 612 more genes
Specificity
1 %
Genes
100 %
GeneAware Complete Panel Version 2 (Female).

By Baylor Miraca Genetics Laboratories (United States).

RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK , (...)

View the complete list with 139 more genes
Specificity
1 %
Genes
100 %
GeneAware Complete Panel Version 2 (Male).

By Baylor Miraca Genetics Laboratories (United States).

RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, TGM1 , (...)

View the complete list with 129 more genes
Specificity
1 %
Genes
100 %
Comprehensive Cardiac Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).

RIT1, RYR2, SCN1B, SCN2B, SCN4B, SCN5A, SGCD, SLC22A5, BRAF, SNTA1, SOS1, TAZ, TCAP, TGFB3, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TTN , (...)

View the complete list with 86 more genes
Specificity
1 %
Genes
100 %
NGS Rhabdomyolysis and Metabolic Myopathies Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).

RYR1, SCN4A, SLC16A1, SUCLA2, TWNK, TK2, TSFM, LPIN1, SLC25A20, CASQ1, CAV3, RRM2B, FKRP, CPT2, SIL1, CTDP1, ANO5, TSEN54, DGUOK, DMD , (...)

View the complete list with 27 more genes
Specificity
3 %
Genes
100 %

You can get up to 117 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

ORPHANET Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B CHROMOSOME 5q DELETION SYNDROME